Relevance of posttranslational modifications for the arthritogenicity of type II collagen.
D000293:Adolescent; D000818:Animals; D001169:Arthritis, Experimental / Q000453:epidemiology / Q000276:immunology*; D001327:Autoimmune Diseases / Q000453:epidemiology / Q000276:immunology; D016367:Baculoviridae / Q000235:genetics; D002417:Cattle; D002478:Cells, Cultured; D024043:Collagen Type II / Q000008:administration & dosage* / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D005260:Female; D006031:Glycosylation; D006801:Humans; D007108:Immune Tolerance; D015994:Incidence; D007271:Injections, Intradermal; D051379:Mice; D008811:Mice, Inbred DBA; D010843:Pichia / Q000235:genetics; D020033:Protein Isoforms / Q000008:administration & dosage / Q000276:immunology / Q000378:metabolism; D011499:Protein Processing, Post-Translational / Q000276:immunology*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000276:immunology / Q000378:metabolism; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000276:immunology
D024043:Collagen Type II; D020033:Protein Isoforms; D011994:Recombinant Proteins